CAS: 1253056-01-7
Sitagliptin Alcohol (3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one)
CAS:1253056-01-7
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, …
Formula:
C16H14F6N4O2
Color and Shape:
Off-White Solid
Molecular weight:
408.10209
Estimated delivery in United States, on Tuesday 7 May 2024
Sitagliptin Impurity 13
CAS:1253056-01-7
Formula:
C16H14F6N4O2
Color and Shape:
White To Off-White Solid
Molecular weight:
408.30
Ref: 4Z-S-2056
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 9 May 2024
![1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone](https://static.cymitquimica.com/products/TR/thumb/D461960.jpg)
1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone
Controlled ProductCAS:1253056-01-7
Applications 1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-hydroxy-4-(2,4,5-trifluorophenyl)-1-butanone is an intermediate in the synthesis of 3-Desamino-2,3-dehydro Sitagliptin (D281985), which is an …
Formula:
C16H14F6N4O2
Color and Shape:
White To Off-White
Molecular weight:
408.3
Ref: TR-D461960
| 100mg | 260.00 € | |
| 250mg | 592.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Sitagliptin hydroxy amide impurity
CAS:1253056-01-7
Sitagliptin is an oral dipeptidyl peptidase-4 inhibitor that is used to treat type 2 diabetes. …
Formula:
C16H14F6N4O2
Purity:
Min. 95%
Molecular weight:
408.3 g/mol
Ref: 3D-IS106472
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire | |
| 500mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
